Recent Research Funding

“Our faculty have great success securing competitive grants that allow us to further our innovative research,” says John Canty Jr., division chief, with fellow Amanda Ribbeck.

We receive funding from a variety of sources that recognize the value of our high-impact research.

With the support of government agencies, foundations, institutes and industry, our faculty make significant contributions to patient health and our understanding of cardiovascular disease.

We’ve been awarded grants from numerous funding sources, including:

  • National Institutes of Health
  • American Heart Association
  • Veterans Health Administration

Some of our recent research efforts, listed by faculty investigator, are as follows:

  • VA Merit Review, 2IO1BX002659, Preventing and Reversing Interstitial Fibrosis in HFpEF. John Canty, Jr. (Principal Investigator). Department of Veterans Affairs. $709,984. 7/1/2020-6/1/2026.
  • Prediction of Arrhythmic Events with Positron Emission Tomography - II (PAREPET II). John Canty, Jr. (Co-Principal Investigator). National Heart Lung and Blood Institute - NHLBI. $3,726,616. 11/1/2016-12/1/2023.
  • The Functional Role of Exosomes in Stem Cell-Mediated Cardiac Repair. Jennifer Lang (Principal Investigator). Veteran‘s Administration. $1,389,635. 10/1/2018-9/1/2023.
  • The Functional Role of Exosomes in Stem Cell Mediated Cardiac Repair. Jennifer Lang (Principal Investigator). NIH/NHLBI. $1,006,430. 12/1/2017-11/1/2022.
  • K12 HL138052 National Heart Lung and Blood Institute, UB Clinical Scholar Program in implementation science to achieve triple aims. John Canty, Jr. (Co-Principal Investigator), Ranjit Singh (Co-Principal Investigator). UB Clinical Scholar Program in Implementation Science to Achieve Triple Aims. $1,022,277. 9/1/2017-8/1/2022.
  • National Institutes of Health/NHLBI, K08. Umesh Sharma (Principal Investigator). NHLBI. $986,850. 7/1/2017-6/1/2022.
  • Prediction ARrhythmic Events with Positron Emission Tomography - II (PAREPET-II). James Fallavollita (Co-Principal Investigator). NIH - NHLBI. 1/1/2016-12/1/2021.
  • Prediction of Arrhythmic Events with Positron Emission Tomography - II (PAREPET II). James Fallavollita (Co-Principal Investigator). National Heart Lung and Blood Institute - NHLBI. $3,726,616. 11/1/2016-12/1/2021.
  • Mobilization of Hematopoietic Progenitors with a Novel Agent. Thomas Cimato (Principal Investigator). Bristol Myers Squibb. 11/1/2019-11/1/2020.
  • Activating Adrenergic Receptors to Suppress the Anti-graft Immune Response and Improve Survival of Composite Tissue Allografts. Umesh Sharma (Consultant). National Institutes of Health/SBIB. $356,467. 7/1/2018-6/1/2020.
  • Liposomal Delivery of a Novel Peptide N-Acetyl-Ser-Asp-Lys-Pro to Inhibit Cancer Radiotherapy-Induced Cardiac Damage. Umesh Sharma (Consultant). National Institutes of Health/NHLBI. $462,000. 4/1/2018-2/1/2020.
  • VA Merit Review, Dynamic remodeling from reversible ischemia and sudden cardiac arrest. John Canty, Jr. (Co-Investigator), James Fallavollita (Co-Investigator). VA. $649,600. 1/1/2016-12/1/2019.
  • The Mae Stone Goode Charitable Trust. Thomas Cimato (Principal Investigator), Brahm Segal (Co-Principal Investigator). $100,000. 3/1/2016-3/1/2019.
  • Validation of a CT based FFR software using the 640 Slices Aquilion Scanner. Ciprian Ionita (Co-Investigator), Vijay Iyer (Co-Investigator). Jacobs Institute. $81,115. 1/1/2017-1/1/2019.